Kenya · Delayed Price · Currency is KES Car & General (Kenya) Statistics
Total Valuation
NASE:CGEN has a market cap or net worth of KES 8.56 billion. The enterprise value is 15.84 billion.
| Market Cap | 8.56B |
| Enterprise Value | 15.84B |
Important Dates
The next confirmed earnings date is Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | Jun 25, 2026 |
Share Statistics
NASE:CGEN has 80.21 million shares outstanding.
| Current Share Class | 80.21M |
| Shares Outstanding | 80.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 11.15% |
| Owned by Institutions (%) | n/a |
| Float | 10.33M |
Valuation Ratios
The trailing PE ratio is 3.50.
| PE Ratio | 3.50 |
| Forward PE | n/a |
| PS Ratio | 0.34 |
| PB Ratio | 1.04 |
| P/TBV Ratio | 1.07 |
| P/FCF Ratio | 9.51 |
| P/OCF Ratio | 6.67 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.42, with an EV/FCF ratio of 17.60.
| EV / Earnings | 6.48 |
| EV / Sales | 0.63 |
| EV / EBITDA | 4.42 |
| EV / EBIT | 4.90 |
| EV / FCF | 17.60 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.94.
| Current Ratio | 1.07 |
| Quick Ratio | 0.40 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | 4.13 |
| Debt / FCF | 8.67 |
| Interest Coverage | 1.50 |
Financial Efficiency
Return on equity (ROE) is 34.78% and return on invested capital (ROIC) is 9.01%.
| Return on Equity (ROE) | 34.78% |
| Return on Assets (ROA) | 4.72% |
| Return on Invested Capital (ROIC) | 9.01% |
| Return on Capital Employed (ROCE) | 13.44% |
| Weighted Average Cost of Capital (WACC) | 7.50% |
| Revenue Per Employee | 19.80M |
| Profits Per Employee | 1.91M |
| Employee Count | 1,280 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 3.41 |
Taxes
In the past 12 months, NASE:CGEN has paid 478.42 million in taxes.
| Income Tax | 478.42M |
| Effective Tax Rate | 16.35% |
Stock Price Statistics
The stock price has increased by +407.13% in the last 52 weeks. The beta is 0.01, so NASE:CGEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | +407.13% |
| 50-Day Moving Average | 77.97 |
| 200-Day Moving Average | 60.36 |
| Relative Strength Index (RSI) | 91.59 |
| Average Volume (20 Days) | 6,728 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NASE:CGEN had revenue of KES 25.34 billion and earned 2.45 billion in profits. Earnings per share was 30.50.
| Revenue | 25.34B |
| Gross Profit | 4.66B |
| Operating Income | 1.54B |
| Pretax Income | 2.93B |
| Net Income | 2.45B |
| EBITDA | 1.74B |
| EBIT | 1.54B |
| Earnings Per Share (EPS) | 30.50 |
Balance Sheet
The company has 792.63 million in cash and 7.80 billion in debt, with a net cash position of -7.01 billion or -87.41 per share.
| Cash & Cash Equivalents | 792.63M |
| Total Debt | 7.80B |
| Net Cash | -7.01B |
| Net Cash Per Share | -87.41 |
| Equity (Book Value) | 8.26B |
| Book Value Per Share | 99.65 |
| Working Capital | 732.21M |
Cash Flow
In the last 12 months, operating cash flow was 1.28 billion and capital expenditures -384.37 million, giving a free cash flow of 900.19 million.
| Operating Cash Flow | 1.28B |
| Capital Expenditures | -384.37M |
| Depreciation & Amortization | 204.86M |
| Net Borrowing | -267.57M |
| Free Cash Flow | 900.19M |
| FCF Per Share | 11.22 |
Margins
Gross margin is 18.40%, with operating and profit margins of 6.07% and 9.65%.
| Gross Margin | 18.40% |
| Operating Margin | 6.07% |
| Pretax Margin | 11.55% |
| Profit Margin | 9.65% |
| EBITDA Margin | 6.88% |
| EBIT Margin | 6.07% |
| FCF Margin | 3.55% |
Dividends & Yields
This stock pays an annual dividend of 3.42, which amounts to a dividend yield of 3.36%.
| Dividend Per Share | 3.42 |
| Dividend Yield | 3.36% |
| Dividend Growth (YoY) | 183.64% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 3.61% |
| Buyback Yield | n/a |
| Shareholder Yield | 3.36% |
| Earnings Yield | 28.57% |
| FCF Yield | 10.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 25, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Mar 25, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
NASE:CGEN has an Altman Z-Score of 1.97 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.97 |
| Piotroski F-Score | 5 |